Private Equity
2 min read · 12 July 2010
National Billing Partners LLC, a Chicago-based provider of financial services for healthcare providers, has raised an undisclosed amount of funding from OCA Ventures.
2 min read · 12 July 2010
iLevel Solutions, a New York-based provider of private equity software and reporting solutions, has raised $6 million in VC funding from Egis Capital Partners, Swift River Investments and Epiphany Ventures.
3 min read · 12 July 2010
Greg Erman has joined Allied Minds as an entrepreneur-in-residence, with a focus on medical technologies. He most recently served as president and CEO of Novo Medical Corp. Allied Minds is an early-stage VC firm focused on commercializing technologies from U.S. universities and national labs.
3 min read · 12 July 2010
Reata Pharmaceuticals Inc., an Irving, Texas-based developer of oral anti-inflammatory drugs, has raised $78 million in new VC funding. Return backers CPMG Inc. and Novo AS co-led the round. Reata Pharma now has raised more than $180 million in total VC funding since its 2002 inception.
3 min read · 12 July 2010
Beyond the Rack, a Montreal-based members-only "flash sale" site, has raised $12 million in new VC funding from Highland Capital Partners and BDC Venture Capital. This is the company's first institutional venture round, having previously been backed by angel investors. www.beyondtherack.com
1 min read · 12 July 2010
The Irish government has launched a €500 million fund-of-funds "to support enterprise development and job creation." Specifically, the vehicle will commit to international VC firms that agree to launch new European operations in Ireland.
4 min read · 12 July 2010
Ubiquisys, a UK-based developer of 3G femtocells, has raised $9 million in new VC funding. Yasuda Enterprise Development Co. led the round, and was joined by return backers Advent Venture Partners, Accel Partners and Atlas Venture.
4 min read · 12 July 2010
Visterra Inc., a Camrbidge, Mass.-based developer of technologies that can interrogate how pathogens interact with human cells, has raised $6 million in first-round funding. Backers include Flagship Ventures, Lux Capital and Polaris Venture Partners. The company is an MIT spinout, and previously was called Parasol Therapeutics.
7 min read · 09 July 2010
1 min read · 09 July 2010
